News

#GESDA Summit 2025: Beyond the Current Model – Advancing Access and Innovation Today at CERN, I joined global experts from Global Antibiotic R&D Partnership (GARDP), WHO, Shionogi Inc. (U.S.), AMR Action Fund, and leading academic institutions to explore how AI, quantum computing, and cross-sector partnerships can reshape the fight against AMR. 🔍 Key discussion focused on AMR/Science Anticipation with Diplomacy AI-driven antibiotic discovery (Matteo Ceccarelli, University of Cagliari) Repurposing & combination therapies (Julia Bielicki, University of Basel) Licensing for equitable access (Pol Vandenbroucke, Shionogi) Insights and perspective form a critical funder (Henni-Karoliina Ropponen, AMR Action Fund) Breaking the silo within AMR and enable the access dimension of AMR (#Ali Cameron, World Health Organization) 💡 AMR demands more than incremental change. We need bold, scalable models that integrate innovation and equity disrupting traditional and ineffective models to address AMR with R&D access as core components 🤝 Co-moderated by Sarah Paulin-Deschenaux (WHO) and Damien N. SOMÉ Somé (GARDP), this session highlighted the urgency of science diplomacy, diversity, inclusion and collaborative action. IFPMA Luka Šrot Health Diplomacy Alliance Katherine Urbáez The Global Fund HUG - Hopitaux Universitaires de Genève Astrid Pentz-Murr Nathalie Khavessian CERN GESDA - Geneva Science and Diplomacy Anticipator #GESDA2025 #AMR #AIforHealth #GlobalHealth #ScienceDiplomacy #GARDP #WHO #Innovation #AccessToMedicines #QuantumComputing #AntibioticResistance